4//SEC Filing
Shanler Stuart 4
Accession 0001209191-19-007488
CIK 0001557746other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:32 PM ET
Size
9.0 KB
Accession
0001209191-19-007488
Insider Transaction Report
Form 4
Shanler Stuart
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2019-02-01+3,875→ 273,355 total - Exercise/Conversion
Restricted Stock Units
2019-02-01−3,875→ 11,625 total→ Common Stock (3,875 underlying) - Tax Payment
Common Stock
2019-02-01$6.96/sh−1,308$9,104→ 272,047 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654332
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:32 PM ET
- Size
- 9.0 KB